Moderna, Inc. — Director's Dealing 2021

Apr 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2021-04-28

Reporting Person: NABEL ELIZABETH G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-28	Stock Option (Right to Buy)	$178.68	A	4081	Acquired	2031-04-28	Common Stock (4081)	Direct
2021-04-28	Restricted Stock Units	$0	A	703	Acquired		Common Stock (703)	Direct

Footnotes

F1: This option will become fully vested and exercisable on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

F2: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.